Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Mayer

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Acta Haematologica|May 5, 2025
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patientsKarin Mayer, Leonie Birk, Katjana Schwab, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2015
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemiaKarin Mayer, Corinna Hahn-Ast, Sara Mückter, et al.
European Journal of Human Genetics : EJHG|October 16, 2004
Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complexMark Nellist, Ozgur Sancak, Miriam A Goedbloed, et al.
The Lancet. Oncology|September 6, 2017
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension studyUwe Platzbecker, Ulrich Germing, Katharina S Götze, et al.
Annals of Hematology|June 27, 2025
Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysisKatharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, et al.
International Journal of Endocrinology|February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive CasesKarin Mayer, Selina Kiry, Anna Yordanova, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Neuropediatrics|October 21, 2020
Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size MattersEva-Katharina Willimsky, Anna Munzig, Karin Mayer, et al.
European Journal of Haematology|May 24, 2018
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisSharifah Shahnaz Syed Abd Kadir, Maximilian Christopeit, Gerald Wulf, et al.
Human Mutation|August 21, 2012
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Acta Haematologica|May 5, 2025
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patientsKarin Mayer, Leonie Birk, Katjana Schwab, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2015
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemiaKarin Mayer, Corinna Hahn-Ast, Sara Mückter, et al.
European Journal of Human Genetics : EJHG|October 16, 2004
Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complexMark Nellist, Ozgur Sancak, Miriam A Goedbloed, et al.
The Lancet. Oncology|September 6, 2017
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension studyUwe Platzbecker, Ulrich Germing, Katharina S Götze, et al.
Annals of Hematology|June 27, 2025
Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysisKatharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, et al.
International Journal of Endocrinology|February 25, 2020
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive CasesKarin Mayer, Selina Kiry, Anna Yordanova, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Neuropediatrics|October 21, 2020
Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size MattersEva-Katharina Willimsky, Anna Munzig, Karin Mayer, et al.
European Journal of Haematology|May 24, 2018
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosisSharifah Shahnaz Syed Abd Kadir, Maximilian Christopeit, Gerald Wulf, et al.
Human Mutation|August 21, 2012
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Pageof 6